Hello, Thanks for signing up for MarketBeat Daily Ratings—we’re excited to have you on board. Every weekday, you’ll get a curated summary of new “Buy” and “Sell” ratings from Wall Street’s top-rated analysts, the latest stock news, and bonus investing content—all delivered straight to your inbox. You’re just two quick steps away from completing your sign-up: 1. Make sure our emails go to your inboxGmail users:
Mobile: Tap the three dots (…) in the top right and select Move to Inbox or Move to Primary
Desktop: Click the folder icon at the top and select Move to Inbox or Primary Apple Mail users:
Tap our email address at the top (next to From: on mobile), then select Add to VIP Other providers:
Reply to this message and add newsletters@analystratings.net to your contacts 2. Confirm your subscriptionClick this link to confirm your subscription. This verifies your account and ensures you receive your newsletters without interruption instead of getting stuck in your spam filter. Confirm your subscription here. After you confirm, feel free to download our popular free report, "7 Stocks to Buy and Hold Forever" with this link. Thanks again for subscribing—we look forward to being part of your investing journey. 
Matthew Paulson
Founder and CEO, MarketBeat. P.S. If you didn’t mean to subscribe, no problem—you can unsubscribe here.
This Week's Featured Content
This New Spinoff Is a Nuclear and AI Chip Beneficiary Worth WatchingAuthored by Leo Miller. Originally Published: 4/1/2026. 
Key Points
- Since splitting off from a massive industrial leader, shares of Solstice Advanced Materials are on a hot streak.
- The company holds impressive positions in nuclear energy and advanced semiconductor supply chains, generating strong growth from these industries.
- However, does the company's overall growth justify its soaring share price?
- Special Report: Have $500? Invest in Elon’s AI Masterplan
Solstice Advanced Materials (NASDAQ: SOLS) is a relatively new public company that has gotten off to a blistering start. At the end of October 2025, the more-than-$100 billion industrial conglomerate Honeywell International (NASDAQ: HON) spun out the business. Since then, Solstice shares have climbed more than 50% as the company benefits from tailwinds in both the nuclear energy and semiconductor markets.
The SpaceX IPO filing is official, with 21 banks - including JPMorgan, Goldman Sachs, and Morgan Stanley - preparing to underwrite what insiders are calling 'Project Apex.' A June timeline is now widely expected.
Dr. Mark Skousen, Macroeconomic Strategist at The Oxford Club, says nearly 15,000 investors have already found a 'backdoor' pre-IPO position - and he's sharing his top pick at no cost before the roadshow begins. Get Dr. Skousen's free SpaceX pre-IPO recommendation before the window closes
Investors should temper enthusiasm, however: the stock's current price already prices in years of growth. Still, because Solstice sits at the intersection of two major secular trends, it is worth watching if valuation retreats meaningfully. U.S. Uranium Conversion Runs Through SolsticeRapid deployment of artificial intelligence (AI) data centers has increased demand for both nuclear power and advanced semiconductors. Many hyperscalers are pushing for faster nuclear adoption as electricity demand rises — a move that supports two objectives: First, nuclear energy is low-carbon, helping companies meet clean-energy commitments. Second, unlike intermittent renewables such as wind and solar, nuclear plants provide constant power, which is valuable for high-demand, continuous AI workloads. Notably, Solstice owns the Metropolis Works uranium hexafluoride (UF6) conversion facility, making it the only domestic provider of UF6 conversion services. The company converts raw uranium into UF6 before it proceeds to other steps in the fuel-fabrication cycle. That position confers strategic importance for U.S. energy security. Solstice says there are only four other UF6 conversion sites worldwide; 2022 data indicate one is in Russia and another in China — nations with adversarial relationships with the United States. With nuclear demand rising, capacity at Metropolis is nearly sold out through 2030 and carries a backlog in excess of $2 billion. Bank of America estimates global nuclear capacity could triple by 2050, creating a sizable opportunity for Solstice in a fragmented market. A key risk is new entrants, but Solstice notes it typically takes four to five years to bring a new UF6 facility into production-ready status. SOLS’s Copper Manganese: A Vital Input for AI SemiconductorsAdvanced semiconductors are central to AI, and Solstice also holds a strong position as a supplier of advanced chip materials. The company produces copper-manganese sputtering targets — essential for manufacturing semiconductors at process nodes below seven nanometers (nm). Solstice says it is "really the only producer that has copper manganese at scale" and counts itself among only two or three global suppliers. Demand for copper-manganese is expected to rise as AI workloads push chipmakers to move to smaller process nodes, which improve performance but increase the need for this material. Reshoring and increased U.S. investment in advanced semiconductor manufacturing also benefit Solstice, as domestic fabs are more likely to source from nearby suppliers. Major industry players are expanding U.S. capacity:
To support rising demand, Solstice is investing $200 million to double its sputtering-target manufacturing capacity at its Washington State facility. Copper-manganese represents another meaningful growth avenue for the company, and management sees substantial runway ahead. SOLS: A Watchlist Stock Amid Demand From High-Growth IndustriesIn its latest quarter, Solstice's nuclear business grew 39% year over year (YOY), while its Electronic Materials division — which includes sputtering-target revenue — grew 19% YOY. That said, Solstice remains a diversified company rather than a pure play on nuclear and semiconductors; in 2024 those two areas combined for only 22% of total revenue. Overall sales rose just 3% YOY in 2025 and 8% YOY in Q4 2025, and management projects roughly 4% revenue growth for 2026. That growth profile is modest relative to the current valuation, which makes the stock's near-term outlook uncertain. Still, Solstice is an interesting company, serving as a key supplier in both the nuclear and semiconductor investment cycles. It remains a stock to watch if its fundamentals or valuation shift materially. |
